Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

290 results about "Acetyl coenzyme" patented technology

Acetyl Coenzyme A. Acetyl coenzyme a. coenzyme a (coa, CoASH, or HSCoA) is a coenzyme, notable for its role in the synthesis and oxidization of fatty acids, and the oxidation of pyruvate in the citric Acid Cycle. It is adapted from β-mercaptoethylamine, panthothenate and adenosine Triphosphate.

Engineering bacterium for co-expressing D-mannitol dehydrogenase and D-glucose dehydrogenase and application

The invention discloses construction and application of an engineering bacterium for co-expressing D-mannitol dehydrogenase and D-glucose dehydrogenase, and belongs to the technical field of genetic engineering. The technical problem to be solved by the invention is how to co-express D-mannitol dehydrogenase and D-glucose dehydrogenase through a biosynthetic pathway. In order to solve the technical problem, the invention provides recombinant escherichia coli. The recombinant escherichia coli is characterized by containing a D-mannitol dehydrogenase gene, a D-glucose dehydrogenase gene, a glucokinase gene, an acetyl coenzyme A synthetase gene, a D-lactose transporter gene, a D-glucose PTS permease-free gene and a pyruvate oxidase-free gene. And no regulator gene of galactose operon is contained. The invention establishes a preparation method for co-producing D-mannitol and sodium gluconate, which has guiding significance for the production of D-mannitol and sodium gluconate.
Owner:MICROCYTO BIOTECHNOLOGY (BEIJING) CO LTD

Increased production of acetyl-coenzyme a and derived products in yeasts

The present disclosure provides a recombinant yeast host cell having a plurality of native and / or heterologous enzymes that function in an engineered metabolic pathway to convert fructose-6-phosphate to acetyl-coenzyme A. The recombinant yeast host cell can be used, for example, in a process for making acetyl-coenzyme A, acetone and / or isopropanol. The plurality of native and / or heterologous enzymes is activated, upregulated, or overexpressed. The plurality of native and / or heterologous enzymes comprises a phosphoketolase; and optionally an acetate kinase; and / or a phosphotransacetylase. The recombinant yeast host cell comprises at least one of: at least two copies of a heterologous nucleic acid molecule encoding the phosphoketolase; a native and / or heterologous enzyme that functions in an engineered non-oxidative pentose phosphate pathway, wherein the native and / or heterologous enzyme is activated, upregulated, or overexpressed; and / or a native and / or heterologous protein that functions in an engineered metabolic pathway to convert pantothenate into acetyl-coenzyme A, wherein the native and / or heterologous protein is activated, upregulated or overexpressed and comprises at least one of: FEN2 or CAB1.
Owner:DANSTAR FERMENT AG +1

Phosphate transketolase mutant and application thereof

The invention provides a phosphoketolase mutant and application thereof. Comprising the following steps: (a) compared with an amino acid sequence as shown in SEQ ID NO.1, the phosphoketolase mutant contains at least one of the following sites: H142, Q321 and E520, and an amino acid sequence which is subjected to amino acid mutation and has a phosphoketolase activity function; or (b) an amino acid sequence which is obtained by substitution and / or deletion and / or addition of one or more conserved amino acid residues of the phosphoketolase mutant and the amino acid sequence shown in (a) and has the same function. The invention provides a new way for converting C1-6 carbon sources into acetyl phosphate or acetyl coenzyme A without carbon loss. The catalytic activity of the phosphorylated transketolase mutant is higher than that of wild type phosphorylated transketolase.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI

Genetically engineered bacterium for producing L-arginine as well as construction method and application of genetically engineered bacterium

PendingCN119320737AImproves the ability to accumulate L-arginineincrease production capacityCarbon-nitrogen lyasesBacteriaEscherichia coliGenetic enhancement
The invention relates to the technical field of genetic engineering, and discloses a genetically engineered bacterium for producing L-arginine as well as a construction method and application of the genetically engineered bacterium. Escherichia coli is taken as a starting strain, and the following treatment is performed: overexpressing genes gdhA and gdh of glutamate dehydrogenase, promoting generation of glutamic acid, overexpressing and coding arginine transporter gene argO to enhance extracellular transport of arginine, introducing exogenous argJ to replace a linear synthesis pathway in large intestines, improving the utilization rate of acetyl coenzyme A and accelerating the synthesis efficiency of arginine; a glutamine synthetase gene glnA is over-expressed, and glutamine synthesis is enhanced; the pckA is overexpressed to promote ATP synthesis; meanwhile, speA and adiA genes for coding the arginine decarboxylase are deleted, so that further synthesis of putrescine from L-arginine is inhibited, and the L-arginine accumulation capability of the strain is improved. Through the combined action of the treatment, a genetically engineered bacterium with extremely high L-arginine production yield is finally obtained, and the shake flask fermentation yield can reach 13.7 g / L.
Owner:ZHEJIANG UNIV OF TECH

Recombinant escherichia coli strain for producing 1, 3-butanediol from glucose and method for producing 1, 3-butanediol by using recombinant escherichia coli strain

The present invention relates to a recombinant Escherichia coli strain for producing 1, 3-butanediol from glucose and a method for producing 1, 3-butanediol by using the same, in which a recombinant Escherichia coli strain is developed in which a gene of a pathway required for biosynthesis of 1, 3-BDO from acetyl-CoA is cloned, and removing genes interfering with the pathway or a pathway competing with the pathway. Furthermore, a strain of Escherichia coli has been developed in which the pathways and genes involved in the conversion of glucose to acetyl-CoA, the rate of regeneration of NADPH used as a cofactor, and the effective utilization of the TCA cycle pathway are modified and optimized, which are necessary to improve the biosynthesis efficiency of 1, 3-BDO. Therefore, the recombinant Escherichia coli strain of the present invention can produce 1, 3-butanediol from glucose at high concentration, high yield, and high rate.
Owner:ACTIVON CO LTD

Lidaldanediol pyrophosphate synthase and engineered yeast for producing sclareol

ActiveCN121450628AFungiTransferasesTranscription RepressorPyrophosphate
The invention belongs to the field of biosynthesis, and in particular relates to LBD (Levandanenediol Pyrophosphate) synthase and engineered yeast for producing sclareol. In order to solve the problem that in the prior art, the sclareol biosynthesis yield is generally low, LSLPPs mutant containing at least one mutation of D730L, D374L, N674L or G379M is obtained by performing mutation and optimization on LSLPPs pyrophosphate synthase, and the mutant is used for sclareol synthesis. Meanwhile, in order to solve the problem of genetic instability caused by free plasmid expression of part of saccharomyces cerevisiae strains, a sclareol synthesis pathway is constructed in a yeast genome, and meanwhile, an acetyl coenzyme A synthesis pathway, an MVA pathway and a sclareol synthesis pathway are enhanced; chassis bacteria for synthesizing sclareol are modified in a manner of knocking out part of transcription inhibition factors, and the yield of a 5L fermentation tank reaches 26.11 g / L and is greatly improved compared with the prior art.
Owner:SICHUAN INGIA BIOSYNTHETIC CO LTD

Recombinant strain for producing squalene as well as construction method and application of recombinant strain

The invention discloses a recombinant strain for producing squalene as well as a construction method and application of the recombinant strain. The construction method comprises the following steps: heterologously expressing cDNA (complementary deoxyribonucleic acid) of each gene in a squalene synthesis route from filamentous fungi in yeast; the squalene synthetic pathway genes comprise a mevalonic acid-5-phosphate kinase gene, a squalene synthase gene, an acetoacetyl coenzyme A thiolase gene, a mevalonic acid kinase gene, a hydroxymethyl glutaryl coenzyme a synthetase gene, a mevalonic acid pyrophosphate decarboxylase gene, a farnesyl pyrophosphate synthetase gene and isopentenyl pyrophosphate. A dimethallylpyrophosphate isomerase gene and a truncated hydroxymethyl glutaryl coenzyme a reductase gene; the culture medium is characterized in that the filamentous fungi are Saroocladium oryzae or Stibella sp. 1056, and the culture medium is a culture medium. The excavated squalene synthesis route can complete efficient de novo synthesis of squalene, and the squalene yield is increased.
Owner:THE INST OF BIOTECHNOLOGY OF THE CHINESE ACAD OF AGRI SCI

Sclareol synthase and engineered yeast for producing sclareol

ActiveCN121450629AFungiTransferasesTranscription RepressorMutant
The invention belongs to the field of biosynthesis, and particularly relates to sclareol synthase and engineered yeast for producing sclareol. In order to solve the problem that in the prior art, sclareol biosynthesis yield is generally low, sclareol synthase is mutated and optimized, an SsScs mutant containing at least one mutation of Y491F, G307L or N269F is obtained, and the mutant is used for sclareol synthesis. Meanwhile, in order to solve the problem of genetic instability caused by free plasmid expression of part of saccharomyces cerevisiae strains, a sclareol synthesis pathway is constructed in a yeast genome, and meanwhile, an acetyl coenzyme A synthesis pathway, an MVA pathway and a sclareol synthesis pathway are enhanced; chassis bacteria for synthesizing sclareol are modified in a manner of knocking out part of transcription inhibition factors, and the yield of a 5L fermentation tank reaches 21.13 g / L and is greatly improved compared with the prior art.
Owner:SICHUAN INGIA BIOSYNTHETIC CO LTD

Pichia pastoris engineering bacterium for synthesizing bakuchiol from de novo by converting methanol as well as construction and application of pichia pastoris engineering bacterium

The invention discloses a pichia pastoris engineering bacterium for synthesizing bakuchiol from de novo by converting methanol as well as construction and application of the pichia pastoris engineering bacterium. A heterologous p-coumaric acid synthesis pathway is introduced to neutral sites of different chromosomes of pichia pastoris, a high-yield p-coumaric acid strain is obtained through gene knockout, overexpression or heterologous expression of tyrosine and phenylalanine synthesis pathway key genes of a shikimic acid pathway, a heterologous bakuchiol biosynthesis pathway is introduced on the basis, and a high-yield p-coumaric acid strain is obtained. After overexpression of bakuchiol synthetase, endogenous overexpression or heterologous expression of MVA pathway key genes and exogenous acetyl coenzyme A supply pathway genes, methanol concentration optimization and bacterial strain His4 gene supplementation, the yield of bakuchiol is effectively increased to 91.2 mg / L and is increased by 59.8 times compared with that of an initial bacterial strain, and the yield of bakuchiol in a 15L fermentation tank reaches 692.8 mg / L. The method has the characteristics of high conversion efficiency, low production cost, convenience in preparation, wide industrial application prospect and the like.
Owner:SOUTH CHINA UNIV OF TECH +1

Method for improving conversion rate of ethanol to acetyl coenzyme A in saccharomycetes, engineering bacteria and application of engineering bacteria in production of 3-hydracrylic acid

The invention relates to a method for improving the conversion rate of ethanol to acetyl coenzyme A in saccharomycetes, engineering bacteria and application of the engineering bacteria in production of 3-hydracrylic acid. Pfk1 and pfk2 genes are deleted from the engineering bacteria; the engineering bacterium is also used for overexpression of mutACC1, MCRC, MCRN, Zwf1, Gnd1, Tal1, Rki1, Rpe1, Tkl1, and fused CaGAPDH and Pos5 genes. The invention further discloses a preparation method of the engineering bacterium. According to the method, a metabolic pathway from ethanol to acetyl coenzyme A is systematically combed and modified in the saccharomyces cerevisiae, so that the conversion rate from ethanol to acetyl coenzyme A is effectively improved, and the reducing power and energy balance in cells are evolved and remodeled through an adaptive laboratory, so that efficient and stable synthesis of 3-hydracrylic acid in the saccharomyces cerevisiae is realized. In addition, by remodeling yeast central metabolism, a new thought is provided for efficient conversion of low-carbon compounds by means of synthetic biology.
Owner:SHENZHEN INST OF ADVANCED TECH +1

Sulfonamide compound, pharmaceutical composition and application thereof

The invention relates to a sulfonyl compound and a pharmaceutical composition and application thereof. The sulfonamide compound comprises a compound as shown in formula I: # imgabs0 #. The sulfonamide compound has a benzyne structure located on the left side of sulfonyl and a pyridino isoxazole structure located on the right side of sulfonyl. Through the synergistic effect of sulfonyl, a benzyne structure and a pyridoisoxazole structure, the druggability of the compound and the capability of competitively combining with acetyl coenzyme to KAT6A / KAT6B can be remarkably improved, the acetyl coenzyme is inhibited from combining with KAT6A / KAT6B to catalyze histone related sites, and gene expression inducing cancer cell growth is prevented; further, the KAT6A / KAT6B gene can be used for treating related tumor diseases caused by KAT6A / KAT6B gene amplification or KAT6A / KAT6B protein overexpression.
Owner:BEIJING KONRUNS PHARM CO LTD

Application of euphorbia lathyris acyltransferase and coding gene thereof in preparation of euphorbia lathyris alkane diterpenoid ester

ActiveCN119570820Ahigh substance contentBacteriaMicrobiological testing/measurementAlkaneAcyl group
The invention provides a euphorbia lathyris acyltransferase gene ElBAHD16 and application of a coding protein thereof. The gene is obtained by cloning from euphorbia lathyris for the first time. The invention also provides a recombinant vector and an engineering bacterium containing the gene. Cinnamoyl coenzyme A, benzoyl coenzyme A or acetyl coenzyme A can be used as an acyl donor, and 7-hydroxy euphorbia lathyris diterpenoid alcohol is used as a substrate to generate a plurality of types of euphorbia lathyris diterpenoid esters through biological catalysis. The content of diterpenoid ester substances in plants such as euphorbia lathyris can be increased through a genetic engineering technology, and the method has a good application prospect.
Owner:INST OF BOTANY JIANGSU PROVINCE & CHINESE ACADEMY OF SCI

Culture medium for regulating acetyl coenzyme A derivative and use method thereof

PendingCN119193394ABacteriaBiofuelsBiotechnologyClostridium autoethanogenum
The invention relates to the technical field of synthesis gas fermentation, in particular to a culture medium for regulating an acetyl coenzyme A derivative and a use method of the culture medium. The culture medium is used for regulating and controlling the yield of ethanol and the yield of acetic acid generated by an acetyl coenzyme A derivative in the ethanol-producing clostridium; the culture medium comprises ferrous sulfate, the weight content of the ferrous sulfate is in negative correlation with the yield of ethanol, and the weight content of the ferrous sulfate is in positive correlation with the yield of acetic acid. According to the culture medium, along with the weight content change of the ferrous sulfate and the content change of the ethanol and the acetic acid generated by the ethanol-producing clostridium, the yield of the ethanol and the acetic acid in a synthetic product of the ethanol-producing clostridium is adjusted by adjusting the content change of the ferrous sulfate; therefore, the controllability of the synthetic product of the clostridium ethanoliforme can be comprehensively improved.
Owner:BEIJING SHOUGANG LANZATECH TECH CO LTD +1

Mixed type central metabolic network chassis cell with both carbon atom economy and energy generation pathway as well as construction method and application of mixed type central metabolic network chassis cell

The invention discloses a hybrid central metabolic network chassis cell with both carbon atom economy and energy generation pathway as well as a construction method and application of the hybrid central metabolic network chassis cell, and belongs to the technical field of genetic engineering and microorganisms. The Escherichia coli central metabolic network is reconstructed, so that the Escherichia coli central metabolic network has a carbon sequestration module and an energy generation module at the same time. The carbon sequestration module continues to fix CO2 while avoiding CO2 release caused by pyruvic acid decarboxylation, the highest carbon yield can reach 133%, the carbon yield exceeds that of an NOG pathway reported only from the perspective of no CO2 release, and the carbon yield is two times that of a natural glycolysis pathway. And the direct product of the constructed mixed type central metabolic network is acetyl coenzyme A, and the acetyl coenzyme A contains an energy generation module, so that the chassis cell provided by the invention can meet the synthesis requirements of acetyl coenzyme A derivatives with high or low required reducing power, and has universality.
Owner:SHANDONG UNIV

Schizochytrium limacinum genetic engineering strain for enhancing supply of acetyl coenzyme A and efficiently producing astaxanthin, method and application

The invention belongs to the technical field of genetic engineering, and discloses a schizochytrium limacinum genetic engineering strain for enhancing supply of acetyl coenzyme A and efficiently producing astaxanthin, a method and application of the schizochytrium limacinum genetic engineering strain. By heterologous expression of a beta-carotene ketolase CrtO gene and a beta-carotene hydroxylase CrtZ gene from haematococcus pluvialis, synthesis of astaxanthin from beta-carotene in schizochytrium limacinum is promoted, so that the content of astaxanthin in schizochytrium limacinum HX-308 is increased. According to the invention, the endogenous AACT gene and heterologous CrtO, CrtZ, PK and PTA genes of schizochytrium limacinum are integrated into an original strain through homologous recombination, and the obtained strain still keeps genetic stability after multiple subculture, has the capability of efficiently synthesizing astaxanthin, effectively improves the yield of astaxanthin, and lays a foundation for large-scale industrial production.
Owner:ZHIHE BIOTECHNOLOGY (CHANGZHOU) CO LTD

Rice ACCase mutant protein and application method thereof

The invention discloses a rice ACCase mutant protein and a preparation method thereof. The amino acid sequence of the ACCase mutant gene encoding protein has the following mutations: the 2052nd site corresponding to the amino acid sequence of wild rice ACCase is mutated, isoleucine (I) is changed into asparagine (N), or isoleucine (I) is changed into glutamine (Q), or isoleucine (I) is changed into cysteine (C), or isoleucine (I) is changed into cysteine (C), or isoleucine (I) is changed into cysteine (C), or isoleucine (I) is changed into cysteine (C), or isoleucine (I) is changed into cysteine (C). And the plant can have extremely strong resistance (tolerance) to acetyl-coenzyme A carboxylase inhibitor herbicides. After the rice containing the rice ACCase mutant protein disclosed by the invention is applied with an acetyl-coenzyme A carboxylase inhibitor herbicide with 8 times of recommended use concentration, plants still grow normally, and the tolerance of the herbicide is greatly enhanced, so that the rice ACCase mutant protein can be widely applied to breeding of herbicide-resistant plants.
Owner:ANHUI AGRICULTURAL UNIVERSITY

L-arginine production strain as well as construction method and application thereof

The invention provides an L-arginine production strain and a construction method and application thereof, corynebacterium glutamicum AJC is modified by a metabolic engineering method to obtain the L-arginine production strain, the synthesis path of arginine is optimized, and a carbon source efficiently flows to arginine by means of promoter replacement, multi-copy and the like; by introducing an exogenous gene pyrABE949 *, the supply of a precursor substance carbamyl phosphate is enhanced; by introducing an exogenous gene pntAB, a new direction is provided for supply of coenzyme NADPH, and a large amount of reducing power is provided for synthesis of arginine; an exogenous gene fxpk is introduced, an NOG system is constructed, an acetyl coenzyme A pool is enriched, a large number of acetyl coenzyme A precursors are provided, and the engineering bacterium has the characteristics of high yield and stability and has good industrial application value in the aspect of fermentation production of L-arginine.
Owner:TIANJIN UNIV OF SCI & TECH +1

Application of ginseng exosomes in the preparation of nanomedicines for the treatment of diabetic ulcer vascular lesions

The present invention discloses the application of ginseng exosomes in the preparation of nanomedicines for treating diabetic ulcer vascular lesions, and relates to the field of biomedicine. The present invention verifies through experiments that ginseng exosomes can reprogram the glycolysis process of vascular endothelial cells under high sugar conditions, and inhibit the expression of acetyl coenzyme A in cells, reduce the production of reactive oxygen species, and then promote the expression of nitric oxide synthase, thereby reducing or reversing cell apoptosis induced by high sugar. Ginseng exosomes are used as nanomedicines to prevent, treat or improve diabetic ulcer microangiopathy. The ginseng exosomes in the present invention have a simple preparation process, low cytotoxicity, high delivery efficiency, and good stability. They can be used as a new type of nanomedicine for the prevention, treatment or improvement of diseases related to diabetic vascular lesions.
Owner:ZHEJIANG UNIV

Recombinant escherichia coli for producing melonic acid and application of recombinant escherichia coli

The invention belongs to the technical field of biology, and particularly relates to recombinant escherichia coli for producing melonic acid and application of the recombinant escherichia coli. Escherichia coli MG1655 is used as a host cell, and HMG-CoA synthetase MvaS gene and HMG-CoA reductase MvaE gene derived from lactobacillus casei, acetyl-coenzyme A acetyltransferase atoB gene derived from escherichia coli, phosphoketoenzyme fxpk gene derived from bifidobacterium adolescentis and fructose-1, 3-D-glucanase derived from escherichia coli are synthesized into an HMG-CoA synthetase MvaS gene and HMG-CoA reductase MvaE gene derived from lactobacillus casei. And transferring the 2, 6-diphosphatase fbp gene into Escherichia coli host cells to obtain the gene. The recombinant Escherichia coli constructed by the invention can be used for synthesis of the melonic acid, the yield of the melonic acid can reach 87.86 g / L after the recombinant Escherichia coli takes glucose as a substrate and is fermented for 48 hours in a 5L fermentation tank at 37 DEG C, and the recombinant Escherichia coli has the advantages of short fermentation time and high yield and meets the requirements of industrial production.
Owner:HANG ZHOU HE TAN CHUANG WU KE JI YOU XIAN GONG SI

Rice herbicide-resistant mutant gene and application thereof

InactiveCN119061031Aavoid damageAvoid problems such as production reductionLigasesFermentationBiotechnologyCoenzyme A biosynthesis
The invention discloses a rice herbicide-resistant mutant gene and application thereof. A mutant gene sequence with strong resistance to acetyl-CoA carboxylase inhibitor herbicides is obtained by mutagenesis and screening from a large number of gene sequences, and the mutant gene sequence is introduced into rice to carry out growth tests under the condition of different herbicide contents. It is proved that the mutant gene can bring resistance (tolerance) to the acetyl-coenzyme A carboxylase inhibitor herbicide to rice, and the mutant gene has important significance on cultivation of herbicide-resistant rice and has great economic value. Besides, in consideration of the excessive use condition of most farmer households in the herbicide use process at present, the resistance under the condition of excessive use of the herbicide is also tested, and the mutant gene has good resistance to plants which are excessively used by the mutant gene disclosed by the invention. The herbicide-resistant mutant gene can be widely applied to herbicide-resistant breeding of plants.
Owner:ANHUI AGRICULTURAL UNIVERSITY

Kluyveromyces marxianus engineering bacterium for synthesizing eicosapentaenoic acid and application of kluyveromyces marxianus engineering bacterium

The invention belongs to the technical field of bioengineering, and particularly relates to kluyveromyces marxianus engineering bacteria for synthesizing eicosapentaenoic acid and application of the kluyveromyces marxianus engineering bacteria. According to the engineering bacterium, pyruvate decarboxylase PDC1 genes, alcohol dehydrogenase ADH1 genes and alcohol dehydrogenase ADH2 genes are sequentially knocked out from a kluyveromyces marxianus FIM1 delta ura3 strain; meanwhile, a citrate lyase ACL gene, a pyruvate oxidase PO gene and a phosphate transacetylase PTA gene are inserted into the loci respectively, so that synthesis of acetyl coenzyme A is enhanced; then a plurality of genes are sequentially inserted into a Kluyveromyces marxianus genome, and then a vector of a delta 8 desaturase delta 8D gene is transferred into the Kluyveromyces marxianus genome. The invention also provides a method for efficiently preparing the EPA, namely the Kluyveromyces marxianus engineering strain is used as a fermentation strain, glucose, a yeast extract, peptone and other components are used as a culture medium, and the yield of the EPA produced by culturing and fermenting reaches 8.71 mg / g of dry cell weight.
Owner:FUDAN UNIVERSITY

Brewer's yeast having low ethanol synthesis and high acetyl-coa synthesis, and use thereof

PCT designated stage expiredWO2025015846A1FungiBiofuelsHeterologousCulture fungus
Provided are a brewer's yeast having low ethanol synthesis and high acetyl-CoA synthesis, and a use thereof, belonging to the technical field of biology. In order to reduce the accumulation of ethanol, the main byproduct of brewer's yeast, and increase synthesis of acetyl-CoA, MTH1, MED2 and HXT2 transcription factors are modified, an optimal transcription factor combination for reducing ethanol synthesis is obtained by screening, and then heterologous acetyl-CoA synthesis pathways of different synthesis pathways integrated in the brewer's yeast genome are compared, and a recombinant brewer's yeast strain is provided. The strain can grow in a sterile culture medium using glucose as a carbon source, creating a platform for modifying brewer's yeast by metabolic engineering, to synthesize high-value compounds; in addition, the construction method is simple and easy to use, and has good application prospects.
Owner:JIANGNAN UNIV

Acetyl coenzyme A carboxylase mutant and application thereof

The invention belongs to the field of biotechnology and crop genetic breeding, and particularly relates to an acetyl coenzyme A carboxylase mutant and application thereof. The invention discloses a mutant acetyl-coenzyme A carboxylase (ACC) protein, a coding nucleic acid thereof and an application of the mutant acetyl-coenzyme A carboxylase (ACC) protein in plant breeding, and particularly provides the mutant acetyl-coenzyme A carboxylase (ACC) protein, and compared with a parent acetyl-coenzyme A carboxylase (ACC) protein, the mutant acetyl-coenzyme A carboxylase (ACC) protein has the advantages that the mutant acetyl-coenzyme A carboxylase (ACC) protein is more stable, and the yield of the mutant acetyl-coenzyme A carboxylase (ACC) protein is higher than that of the parent acetyl-coenzyme A carboxylase (ACC) protein; the rice after the mutation of the corresponding 1927 amino acid and the mutation of acetyl-CoA carboxylase (ACC) has very high herbicide resistance to quizalofop-p-ethyl and haloxyfop-R-methyl, and has a very wide application prospect in the cultivation of herbicide-resistant crops.
Owner:HUNAN ACADEMY OF AGRI SCI

Yarrowia lipolytica with high yield of beta-carotene as well as construction method and application of yarrowia lipolytica

PendingCN120944727AFungiTransferasesLycopersenePhytoene synthesis
The invention discloses yarrowia lipolytica with high yield of beta-carotene as well as a construction method and application of the yarrowia lipolytica. According to the yarrowia lipolytica engineering bacterium, geranyl diphosphate synthase gene xdGPS, phytoene dehydrogenase gene CarB, phytoene cyclization / phytoene synthesis bifunctional enzyme mutant gene GarRPY27R, acetyl-coenzyme A synthetase mutant gene ACSL641P and pyruvate ferredoxin oxidoreductase gene nifJ are integrated and expressed on a chromosome, and the yarrowia lipolytica engineering bacterium is obtained. Meanwhile, a 3-hydroxy-3-methylglutaryl CoA reductase gene HMGR (3-hydroxy-3-methylglutaryl CoA reductase) derived from the yarrowia lipolytica strain is subjected to overexpression; the yield of the beta-carotene is increased to 13.186 g / L, and the production efficiency is 0.14 g / L / h.
Owner:JIANGNAN UNIV

Method for preparing glycine, acetyl coenzyme a, and acetyl coenzyme a derivative by using threonine

PendingUS20250230479A1Carbon-nitrogen lyasesBacteriaCoenzyme A biosynthesisFructose-bisphosphate aldolase
A method for preparing glycine by using threonine relates to a fermentation process in which threonine is decomposed into glycine and acetaldehyde by aldolase. Glycine and acetyl coenzyme A can be produced in a fermentation process, in which acetaldehyde is reduced into acetyl coenzyme A or an acetyl coenzyme A derivative by acetylating acetaldehyde dehydrogenase; or threonine is dehydrogenated by threonine dehydrogenase to obtain 2-amino-3-ketobutyric acid, which is then ligated by 2-amino-3-ketobutyrate CoAligase to obtain acetyl coenzyme A. Coenzyme A can be converted into an acetyl coenzyme A derivative under different fermentation conditions.
Owner:MINT BIOTECH LTD

Method for biosynthesizing dicarbon organic acid by using CO2

The invention discloses a method for biosynthesizing dicarbon organic acid by using CO2, and belongs to the technical field of bioengineering. A path for synthesizing glyoxylic acid and glycollic acid by taking CO2 as a substrate is designed, and a first reaction module for converting CO2 and acetyl coenzyme A into pyruvic acid and a second reaction module for converting pyruvic acid into malic acid are obtained through thermodynamic evaluation and screening of pathase. The third reaction module is used for converting malic acid into acetyl coenzyme A and glyoxylic acid, the fourth reaction module is used for converting glyoxylic acid into glycollic acid, and PSP circulation is carried out on the four reaction modules. Through an experimental method of a one-pot two-step method, 2.78 g / L of glyoxylic acid can be realized after 11 hours of catalytic reaction in total; and 1.78 g / L of glycollic acid. The invention successfully realizes a cell-free biosynthesis method for synthesizing glyoxylic acid and glycollic acid by taking CO2 as a substrate.
Owner:JIANGNAN UNIV

In vitro synthesis of coenzyme a and acetyl-COA for cell-free biocatalysis

The present disclosure relates to multi-enzyme pathways for the in vitro cell-free biosynthesis of the cofactor, coenzyme A ("CoA") from lower-cost substrates, such as D-pantothenate, L-cysteine, and ATP, and the use of these pathways in CoA-dependent cell-free systems for the biobased production of chemicals, such as acetyl-CoA, hexanoyl-CoA, malonyl-CoA, and cannabigerolic acid (CBGA).
Owner:INVIZYNE TECHNOLOGIES INC

Recombinant yarrowia lipolytica with high yield of palmitoleic acid, construction method and application thereof

ActiveCN117736895BFungiHydrolasesPeroxisomal biogenesisδ9 desaturase
The application provides a recombinant Yarrowia lipolytica capable of producing palmitoleic acid at a high yield, a construction method and application thereof, and belongs to the technical field of bioengineering. Yarrowia lipolytica The recombinant Yarrowia lipolytica is obtained by knocking out peroxisome biogenesis factor 10 and triacylglycerol lipase 4 in the genome of Yarrowia lipolytica and inserting an acetyl-CoA carboxylase, a Δ9 desaturase, an acetyl-CoA diacylglycerol acyltransferase, a glycerol-3-phosphate acyltransferase, a lysophosphatidylcholine acyltransferase and a phosphatidylcholine:diacylglycerol acyltransferase gene expression cassette. Experiment proves that the recombinant Yarrowia lipolytica can efficiently ferment and produce palmitoleic acid, and realizes efficient synthesis of the natural product palmitoleic acid from plants in Yarrowia lipolytica.
Owner:NANJING TECH UNIV

Means and methods for producing isobutene from acetyl-CoA

Described is a recombinant organism or microorganism which is capable of enzymatically converting acetyl-CoA into isobutene, (A) wherein in said organism or microorganism: (i) acetyl-CoA is enzymatically converted into acetoacetyl-CoA, (ii) acetoacetyl-CoA is enzymatically converted into 3-hydroxy-3-methylglutaryl-CoA, (iii) 3-hydroxy-3-methylglutaryl-CoA is enzymatically converted into 3-methylglutaconyl-CoA, (iv) 3-methylglutaconyl-CoA is enzymatically converted into 3-methylcrotonyl-CoA, and (v) wherein said 3-methylcrotonyl-CoA is converted into isobutene by: (a) enzymatically converting 3-methylcrotonyl-CoA into 3-methylcrotonic acid which is then further enzymatically converted into said isobutene; or (b) enzymatically converting 3-methylcrotonyl-CoA into 3-hydroxy-3-methylbutyryl-CoA which is then further enzymatically converted into 3-hydroxy-3-methylbutyric acid which is then further enzymatically converted into 3-phosphonoxy-3-methylbutyric acid which is then further enzymatically converted into said isobutene; (B) wherein said recombinant organism or microorganism has an increased pool of coenzyme A (CoA) over the organism or microorganism from which it is derived due to: (i) an increased uptake of pantothenate; and / or (ii) an increased conversion of pantothenate into CoA. Moreover, described is the use of such a recombinant organism or microorganism for the production of isobutene. Further, described is a method for the production of isobutene by culturing such a recombinant organism or microorganism in a suitable culture medium under suitable conditions.
Owner:GLOBAL BIOENERGIES

Engineering strain for producing glycine as well as construction method and application of engineering strain

The invention discloses an engineering strain for producing glycine. The engineering strain is obtained by modifying the following steps: (i) respectively introducing an exogenous acetyl coenzyme A synthetase gene acs, an isocitrate lyase gene aceA and an isocitrate dehydrogenase kinase gene aceK; (ii) introducing a glutamic acid glyoxylate transaminase gene cgaT from quinoa; and (iii) respectively knocking out a DNA (Deoxyribose Nucleic Acid) binding transcription inhibition factor gene iclR, a glycine dehydrogenase gene gcvP, an alanine transaminase gene alaA, a malate dehydrogenase gene maeA and a malate synthetase G gene glcB. According to the invention, an engineering strain capable of efficiently synthesizing glycine is constructed by transforming a glycine biosynthesis metabolic pathway, and the strain can produce glycine by fermentation with glucose as a carbon source and has a relatively high conversion rate.
Owner:NANJING HUASHI NEW MATERIAL CO LTD